Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up.
| Image |  |
|---|---|
| Description | scientific article published on 7 January 2013 |
| Author/s |
author: Michelle Spaan Andre Boonstra |
| Publication date | January 7, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |